Romano Drugs Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.22 M
- Company Age 28 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.57 Cr
- Satisfied Charges ₹ 1.03 Cr
About Romano Drugs
Romano Drugs Private Limited (RDPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 September 1996 and has a history of 28 years and four months. Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.22 M.
The company currently has active open charges totaling ₹1.57 Cr. The company has closed loans amounting to ₹1.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shrikant Deshpande, Swati Deshpande, Avinash Sanas, and One other member serve as directors at the Company.
Company Details
-
Location
Gandhi Nagar, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ1996PTC030650
-
Company No.
030650
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Sep 1996
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Romano Drugs Private Limited offer?
Romano Drugs Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Alcohol Solvents.
Who are the key members and board of directors at Romano Drugs?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shrikant Deshpande
|
Director | 06-Sep-1996 | Current |
|
Swati Deshpande
|
Director | 05-Jun-2023 | Current |
|
Avinash Sanas
|
Additional Director | 05-Feb-2024 | Current |
|
Mohit Chhajed
|
Additional Director | 05-Feb-2024 | Current |
Financial Performance of Romano Drugs.
Romano Drugs Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Romano Drugs?
In 2017, Romano Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sanas Electioneering Consultancy Private LimitedAvinash Sanas is a mutual person
Charges (Loans)
₹15.70 M
₹10.30 M
Charges Breakdown by Lending Institutions
- Others : 1.57 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2023 | Others | ₹1.57 Cr | Open |
| 07 Aug 2012 | Punjab National Bank | ₹8.00 M | Satisfied |
| 17 Nov 1998 | Gujarat State Financial Corporation | ₹2.30 M | Satisfied |
How Many Employees Work at Romano Drugs?
Unlock and access historical data on people associated with Romano Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Romano Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Romano Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
